Asuhan Keperawatan pada Pasien Hiperglikemia dengan Pendekatan Terapi Komplementer
DOI:
https://doi.org/10.47134/phms.v1i3.48Keywords:
Hiperglikemia, Ketidakstabilan Kadar Glukosa Darah, Terapi KomplementerAbstract
Diabetes melitus (DM) adalah penyakit yang tidak dapat berjangkit. Terapi komplementer adalah pengembangan terapi tradisional, yang mencakup integrasi metode pengobatan modern dan bertujuan untuk mempengaruhi keharmonisan individu dari sudut pandang biologis, psikologis, dan spiritual. Beberapa hasil terapi terpadu ini telah lolos uji klinis dan dianggap setara dengan obat-obatan modern. Hal ini sesuai dengan pendekatan pengasuhan yang memandang manusia secara utuh dan mencakup aspek biologis, psikologis, sosial dan spiritual Penyakit ini memiliki tempat dengan kumpulan penyakit metabolik yang digambarkan oleh hiperglikemia kronis karena kelainan pada sekresi bergantungan pada insulin, sedangkan diabetes melitus tipe 2 tidak bergantungan pada insulin. Tujuan pada studi kasus ini bertujuan untuk membahas mengenai masalah pada asuhan keperawatan pada pasien yang mengalami Hiperglikemia dengan Ketidakstabilan Kadar Glukosa Dalam Darah di Kecamatan Kalisat. Metode yang digunakan yakni jenis terapi komplementer dari ramuan herbal. Hasil pada pasien hiperglikemia dengan perbandingan antara 2 klien didapatkan diagnosa yang sama yaitu ketidakstabilan kadar glukosa dalam darah. Kesimpulan yang bisa ditarik dari hasil studi kasus ini adalah asuhan keperawatan yang tepat akan membantu menyelesaikan masalah klien pada ketidakstabilan kadar glukosa dalam darah.
References
Aberer, F. (2019). Feasibility and safety of using an automated decision support system for insulin therapy in the treatment of steroid-induced hyperglycemia in patients with acute graft-versus-host disease: A randomized trial. Journal of Diabetes Investigation, 10(2), 339–342. https://doi.org/10.1111/jdi.12919
Cardona, S. (2021). Sitagliptin for the prevention and treatment of perioperative hyperglycaemia in patients with type 2 diabetes undergoing cardiac surgery: A randomized controlled trial. Diabetes, Obesity and Metabolism, 23(2), 480–488. https://doi.org/10.1111/dom.14241
Damayanti, I. Y., Widada, W., Adi, G. S., Kesehatan, F. I., Jember, U. M., & Diri, M. (2020). Pasien Diabetes Mellitus Type II Di.
Faurholt-Jepsen, D. (2019). Hyperglycemia and insulin function in antiretroviral treatment-naive HIV patients in Ethiopia: A potential new entity of diabetes in HIV? AIDS, 33(10), 1595–1602. https://doi.org/10.1097/QAD.0000000000002249
Harahap, E. T. (2019). Hubungan Pengetahuan, Sikap Dan Dukungan Keluarga Pasien Diabetes Melitus Dengan Pencegahan Hiperglikemia Di Rsud Kotapinang Kabupaten Labuhanbatu Selatan Tahun 2019 [Institut Kesehatan Helvetia]. http://repository.helvetia.ac.id
Herndon, J. (2022). The Effect of Curative Treatment on Hyperglycemia in Patients with Cushing Syndrome. Journal of the Endocrine Society, 6(1). https://doi.org/10.1210/jendso/bvab169
Johnston, K. C. (2019). Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients with Acute Ischemic Stroke: The SHINE Randomized Clinical Trial. JAMA - Journal of the American Medical Association, 322(4), 326–335. https://doi.org/10.1001/jama.2019.9346
Kersten, C. J. B. A. (2022). Association of hyperglycemia and computed tomographic perfusion deficits in patients who underwent endovascular treatment for acute ischemic stroke caused by a proximal intracranial occlusion: A subgroup analysis of a randomized phase 3 trial (MR CLEAN). Journal of the Neurological Sciences, 440. https://doi.org/10.1016/j.jns.2022.120333
Khunti, K. (2018). Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review. Diabetes, Obesity and Metabolism, 20(2), 427–437. https://doi.org/10.1111/dom.13088
Kurniawaty, E., & Lestari, E. E. (2016). Uji Efektivitas Daun Belimbing Wuluh (Averrhoa bilimbi L.) sebagai Pengobatan Diabetes Melitus. Majority, 5(2), 32.
Li, F. (2020). Postoperative hyperglycemia predicts symptomatic intracranial hemorrhage after endovascular treatment in patients with acute anterior circulation large artery occlusion. Journal of the Neurological Sciences, 409. https://doi.org/10.1016/j.jns.2019.116588
Lopez-Huamanrayme, E. (2021). Association between hyperglycemia treatment and mortality in patients with diabetes and COVID-19 in a Peruvian hospital: A retrospective cohort study. Journal of Clinical and Translational Endocrinology, 26. https://doi.org/10.1016/j.jcte.2021.100265
Ma, R. C. W. (2018). Oral glucose lowering with linagliptin and metformin compared with linagliptin alone as initial treatment in Asian patients with newly diagnosed type 2 diabetes and marked hyperglycemia: Subgroup analysis of a randomized clinical trial. Journal of Diabetes Investigation, 9(3), 579–586. https://doi.org/10.1111/jdi.12746
Mirzaei, F. (2021). Importance of hyperglycemia in COVID-19 intensive-care patients: Mechanism and treatment strategy. Primary Care Diabetes, 15(3), 409–416. https://doi.org/10.1016/j.pcd.2021.01.002
Moreira, J. (2018). Hyperglycemia during tuberculosis treatment increases morbidity and mortality in a contemporary cohort of HIV-infected patients in Rio de Janeiro, Brazil. International Journal of Infectious Diseases, 69, 11–19. https://doi.org/10.1016/j.ijid.2017.12.014
Petersmann, A., Nauck, M., Müller-Wieland, D., Kerner, W., Müller, U. A., Landgraf, R., Freckmann, G., & Heinemann, L. (2018). Definition, classification and diagnostics of diabetes mellitus. Journal of Laboratory Medicine, 42(3), 73–79. https://doi.org/10.1515/labmed-2018-0016
Pugliese, G. (2020). Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on “The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function.” Journal of Nephrology, 33(1), 9–35. https://doi.org/10.1007/s40620-019-00650-x
Thalange, N. (2019). The rate of hyperglycemia and ketosis with insulin degludec-based treatment compared with insulin detemir in pediatric patients with type 1 diabetes: An analysis of data from two randomized trials. Pediatric Diabetes, 20(3), 314–320. https://doi.org/10.1111/pedi.12821
Thirumathyam, R. (2022). Investigating the roles of hyperglycaemia, hyperinsulinaemia and elevated free fatty acids in cardiac function in patients with type 2 diabetes via treatment with insulin compared with empagliflozin: protocol for the HyperCarD2 randomised, crossover trial. BMJ Open, 12(8). https://doi.org/10.1136/bmjopen-2021-054100
Torbey, M. T. (2022). Intensive Versus Standard Treatment of Hyperglycemia in Acute Ischemic Stroke Patient: A Randomized Clinical Trial Subgroups Analysis. Stroke, 53(5), 1510–1515. https://doi.org/10.1161/STROKEAHA.120.033048
Tuttle, K. R. (2020). Evidence-based treatment of hyperglycaemia with incretin therapies in patients with type 2 diabetes and advanced chronic kidney disease. Diabetes, Obesity and Metabolism, 22(7), 1014–1023. https://doi.org/10.1111/dom.13986
Widyatuti, W. (2008). Terapi Komplementer Dalam Keperawatan. Jurnal Keperawatan Indonesia, 12(1), 53–57. https://doi.org/10.7454/jki.v12i1.200
Yona, S. (2014). Penyusunan Studi Kasus. Jurnal Keperawatan Indonesia, 10(2), 76–80. https://doi.org/10.7454/jki.v10i2.177
Downloads
Published
How to Cite
